NCT01475617

Brief Summary

Approximately 33% of the US adult population can be classified as obese based on body mass index. This epidemic of obesity has resulted in over 200,000 bariatric surgeries performed every year for the treatment of "clinically severe obesity". Roux-en-Y gastric bypass (RYGB) is the most common bariatric procedure performed in the United States and has both restrictive and malabsorptive components. Despite the success of this procedure in creating long lasting weight loss, vitamin and iron deficiencies are common and can lead to significant morbidity if not appropriately addressed. Despite the American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic \& Bariatric Surgery Medical Guidelines that include vitamin and mineral supplementation recommendations, there has been very little prospective research conducted to assess the efficacy and compliance of these micronutrient interventions. This prospective randomized controlled clinical study will evaluate the efficacy of a novel vitamin/mineral supplement in decreasing micronutrient deficiencies in post operative bariatric patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Nov 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

November 7, 2011

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 21, 2011

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2014

Completed
Last Updated

January 22, 2015

Status Verified

January 1, 2015

Enrollment Period

2.2 years

First QC Date

November 7, 2011

Last Update Submit

January 20, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Plasma vitamin and mineral levels

    3 and 6 months compared to baseline

Secondary Outcomes (1)

  • Questionnaire regarding the palatability of the formulation and the ease of administration of the formats and dosing schedule

    6 months

Study Arms (2)

Novel Multivitamin/Mineral Supplement

EXPERIMENTAL

These subjects will be given a novel multivitamin/mineral supplement post RYGB bariatric surgery for 6 months duration.

Dietary Supplement: AquaVanta Chewable TabletDietary Supplement: Nature Made Calcium Softgels

Standard of care supplement

ACTIVE COMPARATOR

These subjects will be given the standard recommended regimen at Johns Hopkins Bayview Medical Center post RYGB bariatric surgery for 6 months duration.

Dietary Supplement: Flinstones CompleteDietary Supplement: Nature Made Calcium SoftgelsDietary Supplement: Twin Labs Iron CapsDietary Supplement: Rexall Vitamin B12 Tablet

Interventions

AquaVanta Chewable TabletDIETARY_SUPPLEMENT

AquaVanta Chewable Tablet (proprietary formulation of vitamin and minerals) 2 times a day for 6 months

Novel Multivitamin/Mineral Supplement
Flinstones CompleteDIETARY_SUPPLEMENT

Flinstones Complete Multivitamin 2 times a day for 6 months

Standard of care supplement

Nature Made Calcium Softgels (Calcium Carbonate 600 mg and Vitamin D 200 mg) three times a day for 6 months

Novel Multivitamin/Mineral Supplement
Twin Labs Iron CapsDIETARY_SUPPLEMENT

Twin Labs Iron Caps (Ferrous Fumarate) 18 mg per day for menstruating women for 6 months

Standard of care supplement
Rexall Vitamin B12 TabletDIETARY_SUPPLEMENT

Rexall Vitamin B12 Tablet (Cyanocobalamin 500 mcg)per day for 6 months

Standard of care supplement

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ages 18 - 65 years of age
  • Meet appropriate criteria for Roux-en-Y gastric bypass (RYGB) surgery as determined by the Principal Investigator at The John's Hopkins Center for Bariatric Surgery (JHCBS)

You may not qualify if:

  • Allergy to a component of the formulations
  • Recent (last 3 months) use of a dietary supplement other than a standard non-bariatric specific multivitamin supplement
  • Documented levels of fat-soluble vitamins (A,D,E,K) or iron above the normal range
  • Pregnant or lactating
  • Expected poor compliance with medical regimen as assessed by JHCBS clinic care providers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The John's Hopkins Center for Bariatric Surgery (JHCBS)

Baltimore, Maryland, 21224-2780, United States

Location

Related Publications (1)

  • Perin J, Prokopowicz G, Furtado M, Papas K, Steele KE. A Randomized Trial of a Novel Chewable Multivitamin and Mineral Supplement Following Roux-en-Y Gastric Bypass. Obes Surg. 2018 Aug;28(8):2406-2420. doi: 10.1007/s11695-018-3177-0.

Study Officials

  • Kimberley Steele Steele, MD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 7, 2011

First Posted

November 21, 2011

Study Start

November 1, 2011

Primary Completion

January 1, 2014

Study Completion

June 1, 2014

Last Updated

January 22, 2015

Record last verified: 2015-01

Locations